5 Self-Treatment Mistakes with GLP-1: Why Results Are Worse Without a Doctor

Oksana, 34, found Ozempic on a Telegram channel for half the price. Two weeks later, she ended up in the hospital with unbearable nausea and dehydration. It turned out she had injected five times the dose due to confusion with measurement units on the syringe.

This story isn't unique. FDA receives hundreds of reports about overdoses and serious side effects from people taking GLP-1 agonists without medical supervision. And the main problem isn't even the medications themselves. They work. The problem is how people use them.

Why are freely available GLP-1 drugs dangerous?

Semaglutide and tirzepatide-based medications are indeed effective. The SURMOUNT-4 study showed weight loss up to 26% with proper use [20]. But effectiveness doesn't equal safety.

FDA issued an official warning regarding compounded versions of semaglutide and tirzepatide [1]. The agency received reports of serious adverse reactions in patients who used doses higher than those recommended in official instructions. Some people took medications more frequently or increased doses faster than the safe titration schedule.

The problem is compounded by the fact that US legislation doesn't require licensed pharmacies to report adverse effects to FDA. So the real number of cases is significantly higher than official statistics [1].

The European Medicines Agency (EMA) is also concerned. Analysis of the EudraVigilance database revealed psychiatric side effects related to GLP-1 agonists, including suicidal thoughts [3]. This doesn't mean the drugs are dangerous for everyone. It means qualified supervision is needed.

5 critical mistakes of independent use

Mistake 1: Rapid dose escalation

The most common mistake. A person wants faster results and increases the dose earlier than the recommended 4 weeks. Or starts immediately with a high dose.

Official Wegovy titration scheme: 0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg, each step minimum 4 weeks [29]. Mounjaro has a similar scheme: start with 2.5 mg, increase by 2.5 mg every 4 weeks to a maximum of 15 mg.

Why is this important? The body needs time to adapt to delayed gastric emptying. Skipping titration stages causes severe nausea, vomiting, and risk of dehydration that can damage kidneys [40].

Mistake 2: Incorrect dosing due to confusion with units

FDA issued a separate warning about dosing errors with compounded injectable semaglutide products [25]. Most reports describe situations where patients mistakenly drew more medication from multi-dose vials.

Specific example from FDA report: patients were given U-100 insulin syringes to draw small doses (5 units or 0.05 ml). Instead of 5 units, they drew 50 because they confused markings on the syringe [25]. This is a 10-fold dose excess.

Even worse: many patients had no experience with self-injections. They didn't know how to properly draw medication from a vial into a syringe.

Mistake 3: Ignoring side effects

Analysis of 410,198 Reddit posts about semaglutide and tirzepatide revealed that 43.5% of users reported at least one side effect [10]. Most common symptoms: nausea (36.9%), fatigue (16.7%), vomiting (16.3%), constipation (15.3%), diarrhea (12.6%).

Without medical supervision, people either endure these symptoms too long or abruptly stop taking the medication. Both approaches are wrong.

With proper supervision, a specialist adjusts the dose, recommends antiemetics, or temporarily suspends treatment until symptoms resolve.

Mistake 4: Buying counterfeits or unverified products

WHO issued a global warning about falsified versions of Ozempic [2]. Counterfeit batches were found in Brazil, United Kingdom, Northern Ireland, and USA.

Novo Nordisk, Ozempic manufacturer, warns: medicines purchased online or from unlicensed sources may be falsified, contaminated, improperly stored, ineffective, or dangerous [2].

In April 2025, FDA recalled several hundred units of counterfeit Ozempic 1 mg from the American supply chain [7]. Products had batch number PAR0362 and serial numbers beginning with digits 51746517.

MHRA (UK regulator) reported hospitalization cases with hypoglycemic shock and coma from counterfeit GLP-1 pens that likely contained insulin instead of semaglutide [2].

Mistake 5: Lack of medication withdrawal plan

This is the most underestimated mistake. People reach their desired weight and simply stop taking the medication.

The result is predictable. STEP 1 study showed: within a year after stopping semaglutide, participants regained two-thirds of lost weight [17]. SURMOUNT-4 confirmed a similar trend for tirzepatide: most participants gained over 25% of lost weight within a year after discontinuation [21].

This isn't medication failure. This is physiology. Hormones that control appetite and metabolism return to previous levels. Without a result maintenance plan and dietary habit changes, weight returns.

What does medical supervision provide?

Proper titration and dose adjustment

A specialist monitors the body's response to each dose. If side effects are too strong, the dose can be reduced or maintained at the current level longer. If the effect is insufficient, an increase is considered.

If a patient missed several doses, there are clear recovery protocols. For example, for injectable semaglutide: if 3-4 doses are missed, recovery starts with 0.5 mg weekly; if 5 or more, then with the initial dose of 0.25 mg [27].

Side effect management

Gastrointestinal symptoms dominate among GLP-1 side effects. In studies, the most common are: nausea, diarrhea, vomiting, constipation, and abdominal pain [33]. With the right approach, most of them are manageable.

A doctor can prescribe antiemetics during the adaptation period. Recommend frequent small meals. Adjust titration speed. Or suggest a temporary pause.

Health monitoring

Before starting the program, it's important to check kidney, thyroid, and pancreatic function. Some conditions are contraindications: medullary thyroid carcinoma in personal or family history, multiple endocrine neoplasia type 2 [40].

During treatment, kidney function monitoring is needed, especially if gastrointestinal side effects occur. Severe vomiting and diarrhea lead to dehydration, which can cause acute kidney injury [40].

Result maintenance plan

Studies show that long-term treatment is necessary to preserve results. SURMOUNT-4 participants who continued taking tirzepatide from 36 to 88 weeks achieved total weight loss of 26% from baseline [20].

But taking medication forever isn't necessary. A specialist helps plan gradual dose reduction, formation of new dietary habits, and result maintenance after program completion.

What do studies say about result maintenance?

Scientific data is clear: abrupt discontinuation of GLP-1 therapy leads to weight regain and deterioration of metabolic parameters.

SURMOUNT-4 results: participants who stopped tirzepatide after 36 weeks and switched to placebo gained an average of 14% weight back during the following year [19]. Those who continued treatment maintained their results.

Post-hoc analysis of SURMOUNT-4 showed that weight regain was accompanied by deterioration of cardiometabolic parameters compared to those who maintained results [21]. This refers to waist circumference, cholesterol levels, and fasting insulin.

Study authors make a clear conclusion: SURMOUNT-4 results emphasize the need to continue pharmacotherapy to prevent weight gain and ensure preservation of cardiometabolic benefits [20].

This doesn't mean lifelong treatment. This means a plan is needed. Gradual dose reduction. Formation of new eating and physical activity habits. Support after completing the main program.

How is supervision organized at DOZA?

The DOZA weight loss program is built on the principles of medical support at every stage.

The first step is a free consultation. A specialist assesses health status, studies medical history, determines if GLP-1 therapy is suitable for you and which product is optimal specifically for you.

Then individual dose selection and titration schedule. We use original products with proven quality, such as Mounjaro from Eli Lilly UK.

Throughout the entire program, the client is in contact with a specialist. Side effects occurred? You write in chat, get recommendations. Need to adjust dose? We discuss and make decisions together.

Our clients' results show that precisely this approach provides a stable effect. Not just losing weight in a month, but maintaining the result long-term.

Self-treatment with GLP-1 medications is not just ineffective. It's risky. Overdoses, counterfeits, uncontrolled side effects, weight regain after discontinuation. Each of these scenarios can be avoided with proper supervision.

If you're considering weight loss injections as an option, start correctly. A free consultation will help you understand whether this method suits you and how to achieve maximum results without risks.

Where to order DOZA products

DOZA supplies all products mentioned in the article with official cold chain and 24/7 specialist support. Choose what you need:

• Buy Mounjaro in Ukraine — DOZA catalog with all 6 doses (2.5, 5, 7.5, 10, 12.5, 15 mg) and official thermal delivery within 24 hours. Current Mounjaro prices 2026 — from 1,000 ₴ for test dose.
• Buy Ozempic in Ukraine — original semaglutide from Novo Nordisk with thermal delivery. Current Ozempic prices 2026 — from 1,600 ₴ for starter dose.